Recurrent Carotid Stenosis
NCT00000527 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2013-12-11
Summary
To determine whether recurrent stenosis following carotid endarterectomy could be reduced by pre- and post-operative oral administration of platelet-inhibiting drugs.
Conditions
- Cardiovascular Diseases
- Carotid Stenosis
- Cerebrovascular Disorders
- Heart Diseases
- Vascular Diseases
Interventions
- DRUG
- DRUG
-
dipyridamole
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
collaborator NIH -
Emory University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1986-08-31
- Primary Completion
- 1998-11-30
- Completion
- 1998-11-30
More Related Trials
-
Pharmacodynamic Effects of Dabigatran in Patients on Dual Antiplatelet Therapy
NCT01852162 ·Status: COMPLETED ·Phase: NA
-
Warfarin Versus Aspirin Recurrent Stroke Study
NCT00027066 ·Status: COMPLETED ·Phase: PHASE3
-
Dual Antiplatelet Therapy Versus Oral Anticoagulation for a Short Time to Prevent Cerebral Embolism After TAVI
NCT01642134 ·Status: COMPLETED ·Phase: PHASE4
-
Synergy Between Stent and Drugs to Avoid Ischemic Recurrences After Percutaneous Coronary Intervention
NCT00611286 ·Status: COMPLETED ·Phase: PHASE4
-
Platelet Drug Trial in Coronary Disease Progression
NCT00000496 ·Status: COMPLETED ·Phase: PHASE3
-
PPARGC1β and CNTN4 Genotype Aspirin Study
NCT02970604 ·Status: UNKNOWN ·Phase: PHASE4
-
Cardiovascular Disease (CVD) Risk and Prevention in Early Glucose Intolerance
NCT00122447 ·Status: COMPLETED ·Phase: NA
-
Aspirin Twice Daily in Diabetic Patients With Coronary Artery Disease
NCT01617031 ·Status: COMPLETED
-
Colchicine in Atrial Fibrillation to Prevent Stroke
NCT02282098 ·Status: COMPLETED ·Phase: PHASE3
-
Clopidogrel With Aspirin in High-risk Patients With Acute Non-disabling Cerebrovascular Events II
NCT04078737 ·Status: COMPLETED ·Phase: PHASE3
-
Aspirin Or Warfarin To Prevent Stroke
NCT00004728 ·Status: TERMINATED ·Phase: PHASE3
-
Combining Aspirin With Ticagrelor or Cilostazol in Large-vessel Minor Stroke or TIA
NCT06591377 ·Status: RECRUITING ·Phase: PHASE3
-
Study to Investigate Safety and Tolerability of a Single Dose of AZD6482
NCT00688714 ·Status: COMPLETED ·Phase: PHASE1
-
Pilot Study of Aspirin Versus Warfarin for Cervicocephalic Arterial Dissection
NCT00265408 ·Status: WITHDRAWN ·Phase: PHASE1
-
Apixaban Versus Dual-antiplatelet Therapy (Clopidogrel and Aspirin) in Acute Non-disabling Cerebrovascular Events
NCT01924325 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
A Study to Evaluate BMS-986141 Added on to Aspirin or Ticagrelor or the Combination, on Thrombus Formation in a Thrombosis Chamber Model in Participants With Stable Coronary Artery Disease and Healthy Participants
NCT05093790 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacogenomics of Antiplatelet Response
NCT02234427 ·Status: COMPLETED ·Phase: PHASE4
-
Hirudin Plus Aspirin in the Secondary Prevention of Cardioembolic Stroke Due to Nonvalvular Atrial Fibrillation
NCT02181361 ·Status: COMPLETED
-
Aspirin in Patients With Myocardial Infarction and Thrombocytopenia
NCT00501345 ·Status: TERMINATED ·Phase: PHASE3
-
Loss of Effect of Aspirin on Platelet Aggregation During Chronic Administration
NCT00748371 ·Status: TERMINATED ·Phase: PHASE4
-
Perioperative Aspirin Response in Patients Undergoing Vascular Surgery
NCT03587324 ·Status: COMPLETED ·Phase: NA
-
Why Does Aspirin Fail in Secondary Cerebrovascular Prevention? A Multicenter Prospective Case - Control Study
NCT05247931 ·Status: UNKNOWN
-
Antiplatelet Effects in Stroke-Patients
NCT02148939 ·Status: COMPLETED
-
The Middle East Dual Anti-platelet Treatment in Acute Transient Ischemic Attack
NCT02144831 ·Status: WITHDRAWN ·Phase: PHASE4
-
The Vascular Biology of Dipyridamole in Peripheral Arterial Disease (PAD)
NCT00906035 ·Status: TERMINATED ·Phase: NA